We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children With Seasonal Allergies

- Seasonal Female, Maleergic Rhinitis | SAR
- Completed

Study Title: Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Female, Maleergies

Teva Identifier: BDP-AR-305

ClinicalTrials.gov Identifier: NCT01307319

Study Status: Completed

Trial Condition(s): Seasonal Female, Maleergic Rhinitis | SAR

Interventions: Drug: BDP HFA | Drug: Placebo nasal aerosol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender: Female, Male

Age Range: 6 Years to 11 Years

Trial Duration: 03/01/2011 - 08/01/2011

Phase: Phase 3

Study Type

Interventional